Addex Therapeutics Financials
| ADXN Stock | CHF 0.06 0.0008 1.38% |
Addex |
Understanding current and past Addex Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Addex Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Addex Therapeutics' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Addex Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Addex Therapeutics. Check Addex Therapeutics' Beneish M Score to see the likelihood of Addex Therapeutics' management manipulating its earnings.
Addex Therapeutics Stock Summary
Addex Therapeutics competes with Santhera Pharmaceuticals, Newron Pharmaceuticals, Basilea Pharmaceutica, Evolva Holding, and COSMO Pharmaceuticals. Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system disorders in Switzerland. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Plan-les-Ouates, Switzerland. ADDEX N operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 17 people.| Foreign Associate | USA |
| Instrument | Switzerland Stock View All |
| Exchange | SIX Swiss Exchange |
| ISIN | CH0029850754 |
| Business Address | Chemin des Mines |
| Benchmark | Dow Jones Industrial |
| Website | www.addexpharma.com |
| Phone | (41) 22 884 15 56 |
| Currency | CHF - Swiss Franc |
You should never invest in Addex Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Addex Stock, because this is throwing your money away. Analyzing the key information contained in Addex Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Addex Therapeutics Key Financial Ratios
There are many critical financial ratios that Addex Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Addex Therapeutics reports annually and quarterly.Addex Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Addex Therapeutics's current stock value. Our valuation model uses many indicators to compare Addex Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Addex Therapeutics competition to find correlations between indicators driving Addex Therapeutics's intrinsic value. More Info.Addex Therapeutics is rated third in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Addex Therapeutics' earnings, one of the primary drivers of an investment's value.Addex Therapeutics Systematic Risk
Addex Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Addex Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Addex Therapeutics correlated with the market. If Beta is less than 0 Addex Therapeutics generally moves in the opposite direction as compared to the market. If Addex Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Addex Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Addex Therapeutics is generally in the same direction as the market. If Beta > 1 Addex Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Addex Therapeutics March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Addex Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Addex Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Addex Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Addex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Addex Therapeutics's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.75 | |||
| Information Ratio | 0.0259 | |||
| Maximum Drawdown | 38.84 | |||
| Value At Risk | (9.04) | |||
| Potential Upside | 9.45 |
Additional Tools for Addex Stock Analysis
When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.